- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: EGFRvIII-specific hinge-optimized CD3 ζ-stimulatory/41BB-co-stimulatory Chimeric Antigen Receptor au
Total 6 results
-
Chembrain LTDUniversity of Oulu; Jyväskylä Central Hospital; Apollo Hospital, New Delhi, IndiaActive, not recruitingGlioblastoma | Glioblastoma Multiforme | Glioma, MalignantFinland, India
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingGlioblastoma | Ependymoma | Medulloblastoma | Recurrent Metastatic Malignant Neoplasm in the LeptomeningesUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Active, not recruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Refractory Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Refractory Glioblastoma | Refractory WHO Grade II Glioma | Refractory WHO Grade III GliomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Glioblastoma | Refractory GlioblastomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMalignant Brain Neoplasm | Recurrent Malignant Brain Neoplasm | Refractory Malignant Brain NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterParker Institute for Cancer Immunotherapy; California Institute for Regenerative... and other collaboratorsRecruitingBreast Cancer | Neuroendocrine Tumors | Lung Adenocarcinoma | Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma | Refractory Malignant Solid Neoplasm | Thyroid Cancer | Pheochromocytoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Pathologic Stage IIIC Cutaneous Melanoma... and other conditionsUnited States